A

Alexion Pharmaceuticals, Inc.

4439 employees

Alexion Pharmaceuticals is a biopharmaceutical company that engages in the development and commercialization of mid-to-late-stage therapies.

Investor insights

Sectors invested in

Biotechnology and mRNA Therapeutics2
Biotechnology2
Health Care2
Medical2
Pharmaceutical2
Genetics2

Funding rounds participated in

$238M sweet spot round size

Most of their 2 investments are in rounds between $25M and $450M

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurology
Rare Diseases
Metabolic Disorders
Health Care
Complement Inhibition
Research and Development
Therapeutics
nephrology
hematology
Medical
Biopharmaceutical

Date founded

1992

Investments made

M

Moderna raised $450M on January 5, 2015

Investors: Viking Global Investors, The Invus Group, RA Capital Management, L.P., Wellington Management and Alexion Pharmaceuticals, Inc.

M

Moderna raised $25M on January 14, 2014

Investors: Alexion Pharmaceuticals, Inc.

FAQ